bispecific antibodies in multiple myeloma | dana-farber cancer institute
Published 1 year ago • 3.4K plays • Length 23:13Download video MP4
Download video MP3
Similar videos
-
28:40
bispecific antibody therapy in multiple myeloma
-
26:14
multiple myeloma symposium: immunology| dana-farber cancer institute
-
47:54
multiple myeloma symposium: emerging treatment options | dana-farber cancer institute
-
34:55
multiple myeloma symposium: diagnosis and risk assessment | dana-farber cancer institute
-
1:13:39
multiple myeloma: emerging treatment options | dana-farber cancer institute
-
43:52
multiple myeloma: diagnosis and risk assessment | dana-farber cancer institute
-
35:43
multiple myeloma: bone health | dana-farber cancer institute
-
2:28
multiple myeloma precursor clinical trial helps patient | dana-farber cancer institute
-
36:50
multiple myeloma symposium: q & a with faculty| dana-farber cancer institute
-
0:25
how bispecific antibodies work
-
0:24
how bispecific antibodies work
-
26:26
myeloma 101: diagnosis, prognosis & risk | dana-farber cancer institute
-
57:29
multiple myeloma: a patient’s perspective | dana-farber cancer institute
-
46:47
multiple myeloma: symptom management | dana-farber cancer institute
-
1:55
bispecific antibodies for myeloma | patient eligibility requirements
-
1:03:09
treating myeloma at the dana-farber cancer institute | mcrt may 8, 2021
-
44:53
update in multiple myeloma
-
29:29
dr. munshi on diagnosis and risk assessment in multiple myeloma | dana-farber cancer institute
-
42:57
cellular immunotherapy for the treatment of multiple myeloma